NCT01400438View on ClinicalTrials.gov

Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

September 30, 2015

Conditions
Breast Cancer
Interventions
OTHER

questionnaires

delivery of questionnaires and self-psychological interview

OTHER

questionnaires

delivery of questionnaires and self-psychological interview

Trial Locations (1)

14076

Centre François BACLESSE, Caen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER

NCT01400438 - Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer | Biotech Hunter | Biotech Hunter